Disease Modification in Parkinson’s Disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-08

AUTHORS

Claire Henchcliffe, W. Lawrence Severt

ABSTRACT

Parkinson's disease (PD) is an age-related, progressive, multisystem neurodegenerative disorder resulting in significant morbidity and mortality, as well as a growing social and financial burden in an aging population. The hallmark of PD is loss of dopaminergic neurons of the substantia nigra pars compacta, leading to bradykinesia, rigidity and tremor. Current pharmacological treatment is therefore centred upon dopamine replacement to alleviate symptoms. However, two major problems complicate this approach: (i) motor symptoms continue to progress, requiring increasing doses of medication, which result in both short-term adverse effects and intermediate- to long-term motor complications; (ii) dopamine replacement does little to treat non-dopaminergic motor and non-motor symptoms, which are an important source of morbidity, including dementia, sleep disturbances, depression, orthostatic hypotension, and postural instability leading to falls. It is critical, therefore, to develop a broader and more fundamental therapeutic approach to PD, and major research efforts have focused upon developing neuroprotective interventions. Despite many encouraging preclinical data suggesting the possibility of addressing the underlying pathophysiology by slowing cell loss, efforts to translate this into the clinical realm have largely proved disappointing in the past. Barriers to finding neuroprotective or disease-modifying drugs in PD include a lack of validated biomarkers of progression, which hampers clinical trial design and interpretation; difficulties separating symptomatic and neuroprotective effects of candidate neuroprotective therapies; and possibly fundamental flaws in some of the basic preclinical models and testing. However, three recent clinical trials have used a novel delayed-start design in an attempt to overcome some of these roadblocks. While not examining markers of cell loss and function, which would determine neuroprotective effects, this trial design pragmatically tests whether earlier versus later intervention is beneficial. If positive (i.e. if an earlier intervention proves more effective), this demonstrates disease modification, which could result from neuroprotection or from other mechanisms. This strategy therefore provides a first step towards supporting neuroprotection in PD. Of the three delayed-start design clinical trials, two have investigated early versus later start of rasagiline, a specific irreversible monoamine oxidase B inhibitor. Each trial has supported, although not proven, disease-modifying effects. A third delayed-start-design clinical trial examining potential disease-modifying effects of pramipexole has unfortunately reportedly been negative according to preliminary presentations. The suggestion that rasagiline is disease modifying is made all the more compelling by in vitro and PD animal-model studies in which rasagiline was shown to have neuroprotective effects. In this review, we examine efforts to demonstrate neuroprotection in PD to date, describe ongoing neuroprotection trials, and critically discuss the results of the most recent delayed-start clinical trials that test possible disease-modifying activities of rasagiline and pramipexole in PD. More... »

PAGES

605-615

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/11591320-000000000-00000

DOI

http://dx.doi.org/10.2165/11591320-000000000-00000

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047459014

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21812497


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Parkinson Disease", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cornell University", 
          "id": "https://www.grid.ac/institutes/grid.5386.8", 
          "name": [
            "Department of Neurology and Neuroscience, Weill Medical College of Cornell University, 428 East 72nd Street, Suite 400, 10021, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Henchcliffe", 
        "givenName": "Claire", 
        "id": "sg:person.0713775262.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713775262.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mount Sinai Beth Israel", 
          "id": "https://www.grid.ac/institutes/grid.471368.f", 
          "name": [
            "Beth Israel Mirken Department of Neurology, Beth Israel Medical Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Severt", 
        "givenName": "W. Lawrence", 
        "id": "sg:person.0766701226.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766701226.04"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01245973", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001034297", 
          "https://doi.org/10.1007/bf01245973"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1749-6632.2001.tb03656.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002280769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.284.15.1931", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002894278"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1474-4422(05)70097-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003434219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1460-9568.2005.04438.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003894227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/03007990903364954", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007341409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1468-1331.2010.03088.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007376153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneur.61.4.561", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008462073"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneur.59.10.1541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011372686"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0014053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011479076"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/mds.22402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014766341"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.10191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014861123"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001756-199803090-00026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016403129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001756-199803090-00026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016403129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneurol.2009.32", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017092484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0006-8993(99)01688-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018340868"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0014-2999(85)90168-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019162508"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0014-2999(85)90168-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019162508"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0024-3205(00)00643-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021318758"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.20789", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021766477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.20789", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021766477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1196/annals.1403.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023276697"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pneurobio.2010.06.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023363263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/aje/kwm127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025537138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11064-010-0214-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026606925", 
          "https://doi.org/10.1007/s11064-010-0214-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11064-010-0214-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026606925", 
          "https://doi.org/10.1007/s11064-010-0214-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1353-8020(09)70325-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028861053"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/mds.23143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030844858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/mds.23143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030844858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/mds.22432", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031487403"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrneurol.2009.214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031698289", 
          "https://doi.org/10.1038/nrneurol.2009.214"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrneurol.2009.214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031698289", 
          "https://doi.org/10.1038/nrneurol.2009.214"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuint.2010.06.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032101093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.10609", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034488188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0809335", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034534938"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa033447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035458376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/mds.22340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037630113"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1474-4422(07)70246-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039369930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneurol.2009.247", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044051119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0304-3940(02)00332-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045518608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/mds.21918", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045646895"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199301213280305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045752174"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/syn.10239", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046243568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneur.59.12.1937", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046569323"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmsm0904209", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048073707"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1353-8020(09)70832-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048555769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0892-0362(02)00221-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048620190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.287.13.1653", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049579881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/j.nurt.2008.02.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052291159", 
          "https://doi.org/10.1016/j.nurt.2008.02.003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/mds.20914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052764064"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneur.56.5.529", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053022109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.2502843", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062541253"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000201252.57661.e1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064347889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000201252.57661.e1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064347889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000201252.57661.e1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064347889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181d7d8e2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181d7d8e2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181d7d8e2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181d7d94b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181d7d94b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181d7d94b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.51.2.520", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064376556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.51.2.520", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064376556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.51.2.520", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064376556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.56.11.1559", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379306"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.56.11.1559", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379306"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.56.11.1559", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379306"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074268049", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074560399", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077122196", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneur.66.1.nct90001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077897550"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-08", 
    "datePublishedReg": "2011-08-01", 
    "description": "Parkinson's disease (PD) is an age-related, progressive, multisystem neurodegenerative disorder resulting in significant morbidity and mortality, as well as a growing social and financial burden in an aging population. The hallmark of PD is loss of dopaminergic neurons of the substantia nigra pars compacta, leading to bradykinesia, rigidity and tremor. Current pharmacological treatment is therefore centred upon dopamine replacement to alleviate symptoms. However, two major problems complicate this approach: (i) motor symptoms continue to progress, requiring increasing doses of medication, which result in both short-term adverse effects and intermediate- to long-term motor complications; (ii) dopamine replacement does little to treat non-dopaminergic motor and non-motor symptoms, which are an important source of morbidity, including dementia, sleep disturbances, depression, orthostatic hypotension, and postural instability leading to falls. It is critical, therefore, to develop a broader and more fundamental therapeutic approach to PD, and major research efforts have focused upon developing neuroprotective interventions. Despite many encouraging preclinical data suggesting the possibility of addressing the underlying pathophysiology by slowing cell loss, efforts to translate this into the clinical realm have largely proved disappointing in the past. Barriers to finding neuroprotective or disease-modifying drugs in PD include a lack of validated biomarkers of progression, which hampers clinical trial design and interpretation; difficulties separating symptomatic and neuroprotective effects of candidate neuroprotective therapies; and possibly fundamental flaws in some of the basic preclinical models and testing. However, three recent clinical trials have used a novel delayed-start design in an attempt to overcome some of these roadblocks. While not examining markers of cell loss and function, which would determine neuroprotective effects, this trial design pragmatically tests whether earlier versus later intervention is beneficial. If positive (i.e. if an earlier intervention proves more effective), this demonstrates disease modification, which could result from neuroprotection or from other mechanisms. This strategy therefore provides a first step towards supporting neuroprotection in PD. Of the three delayed-start design clinical trials, two have investigated early versus later start of rasagiline, a specific irreversible monoamine oxidase B inhibitor. Each trial has supported, although not proven, disease-modifying effects. A third delayed-start-design clinical trial examining potential disease-modifying effects of pramipexole has unfortunately reportedly been negative according to preliminary presentations. The suggestion that rasagiline is disease modifying is made all the more compelling by in vitro and PD animal-model studies in which rasagiline was shown to have neuroprotective effects. In this review, we examine efforts to demonstrate neuroprotection in PD to date, describe ongoing neuroprotection trials, and critically discuss the results of the most recent delayed-start clinical trials that test possible disease-modifying activities of rasagiline and pramipexole in PD.", 
    "genre": "research_article", 
    "id": "sg:pub.10.2165/11591320-000000000-00000", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100990", 
        "issn": [
          "1170-229X", 
          "1179-1969"
        ], 
        "name": "Drugs & Aging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "name": "Disease Modification in Parkinson\u2019s Disease", 
    "pagination": "605-615", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e21457ab873d6e6c6da8df12d46590141fcc6f13e19f7674684b7a487e16a9bf"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21812497"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9102074"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/11591320-000000000-00000"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047459014"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/11591320-000000000-00000", 
      "https://app.dimensions.ai/details/publication/pub.1047459014"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T23:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000537.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.2165%2F11591320-000000000-00000"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/11591320-000000000-00000'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/11591320-000000000-00000'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/11591320-000000000-00000'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/11591320-000000000-00000'


 

This table displays all metadata directly associated to this object as RDF triples.

265 TRIPLES      21 PREDICATES      89 URIs      26 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/11591320-000000000-00000 schema:about N685cb7a5c185440fb19dd8a628e06eec
2 Nb23a6f7b17d84fd7a07d99e2255affad
3 Nb8b66adfa9184f28852ab16d41855793
4 Ne86d079d1a2745dbae8d2fbe4baaf23e
5 Nf320f7ef101d44908565d40375d964a5
6 anzsrc-for:11
7 anzsrc-for:1109
8 schema:author N7186cf74b70541359125954a3d6eefb8
9 schema:citation sg:pub.10.1007/bf01245973
10 sg:pub.10.1007/s11064-010-0214-3
11 sg:pub.10.1016/j.nurt.2008.02.003
12 sg:pub.10.1038/nrneurol.2009.214
13 https://app.dimensions.ai/details/publication/pub.1074268049
14 https://app.dimensions.ai/details/publication/pub.1074560399
15 https://app.dimensions.ai/details/publication/pub.1077122196
16 https://doi.org/10.1001/archneur.56.5.529
17 https://doi.org/10.1001/archneur.59.10.1541
18 https://doi.org/10.1001/archneur.59.12.1937
19 https://doi.org/10.1001/archneur.61.4.561
20 https://doi.org/10.1001/archneur.66.1.nct90001
21 https://doi.org/10.1001/archneurol.2009.247
22 https://doi.org/10.1001/archneurol.2009.32
23 https://doi.org/10.1001/jama.284.15.1931
24 https://doi.org/10.1001/jama.287.13.1653
25 https://doi.org/10.1002/ana.10191
26 https://doi.org/10.1002/ana.10609
27 https://doi.org/10.1002/ana.20789
28 https://doi.org/10.1002/mds.20914
29 https://doi.org/10.1002/mds.21918
30 https://doi.org/10.1002/mds.22340
31 https://doi.org/10.1002/mds.22402
32 https://doi.org/10.1002/mds.22432
33 https://doi.org/10.1002/mds.23143
34 https://doi.org/10.1002/syn.10239
35 https://doi.org/10.1016/0014-2999(85)90168-2
36 https://doi.org/10.1016/j.neuint.2010.06.017
37 https://doi.org/10.1016/j.pneurobio.2010.06.008
38 https://doi.org/10.1016/s0006-8993(99)01688-1
39 https://doi.org/10.1016/s0024-3205(00)00643-3
40 https://doi.org/10.1016/s0304-3940(02)00332-4
41 https://doi.org/10.1016/s0892-0362(02)00221-0
42 https://doi.org/10.1016/s1353-8020(09)70325-6
43 https://doi.org/10.1016/s1353-8020(09)70832-6
44 https://doi.org/10.1016/s1474-4422(05)70097-1
45 https://doi.org/10.1016/s1474-4422(07)70246-6
46 https://doi.org/10.1056/nejm199301213280305
47 https://doi.org/10.1056/nejmoa033447
48 https://doi.org/10.1056/nejmoa0809335
49 https://doi.org/10.1056/nejmsm0904209
50 https://doi.org/10.1093/aje/kwm127
51 https://doi.org/10.1097/00001756-199803090-00026
52 https://doi.org/10.1111/j.1460-9568.2005.04438.x
53 https://doi.org/10.1111/j.1468-1331.2010.03088.x
54 https://doi.org/10.1111/j.1749-6632.2001.tb03656.x
55 https://doi.org/10.1126/science.2502843
56 https://doi.org/10.1185/03007990903364954
57 https://doi.org/10.1196/annals.1403.011
58 https://doi.org/10.1212/01.wnl.0000201252.57661.e1
59 https://doi.org/10.1212/wnl.0b013e3181d7d8e2
60 https://doi.org/10.1212/wnl.0b013e3181d7d94b
61 https://doi.org/10.1212/wnl.51.2.520
62 https://doi.org/10.1212/wnl.56.11.1559
63 https://doi.org/10.1371/journal.pone.0014053
64 schema:datePublished 2011-08
65 schema:datePublishedReg 2011-08-01
66 schema:description Parkinson's disease (PD) is an age-related, progressive, multisystem neurodegenerative disorder resulting in significant morbidity and mortality, as well as a growing social and financial burden in an aging population. The hallmark of PD is loss of dopaminergic neurons of the substantia nigra pars compacta, leading to bradykinesia, rigidity and tremor. Current pharmacological treatment is therefore centred upon dopamine replacement to alleviate symptoms. However, two major problems complicate this approach: (i) motor symptoms continue to progress, requiring increasing doses of medication, which result in both short-term adverse effects and intermediate- to long-term motor complications; (ii) dopamine replacement does little to treat non-dopaminergic motor and non-motor symptoms, which are an important source of morbidity, including dementia, sleep disturbances, depression, orthostatic hypotension, and postural instability leading to falls. It is critical, therefore, to develop a broader and more fundamental therapeutic approach to PD, and major research efforts have focused upon developing neuroprotective interventions. Despite many encouraging preclinical data suggesting the possibility of addressing the underlying pathophysiology by slowing cell loss, efforts to translate this into the clinical realm have largely proved disappointing in the past. Barriers to finding neuroprotective or disease-modifying drugs in PD include a lack of validated biomarkers of progression, which hampers clinical trial design and interpretation; difficulties separating symptomatic and neuroprotective effects of candidate neuroprotective therapies; and possibly fundamental flaws in some of the basic preclinical models and testing. However, three recent clinical trials have used a novel delayed-start design in an attempt to overcome some of these roadblocks. While not examining markers of cell loss and function, which would determine neuroprotective effects, this trial design pragmatically tests whether earlier versus later intervention is beneficial. If positive (i.e. if an earlier intervention proves more effective), this demonstrates disease modification, which could result from neuroprotection or from other mechanisms. This strategy therefore provides a first step towards supporting neuroprotection in PD. Of the three delayed-start design clinical trials, two have investigated early versus later start of rasagiline, a specific irreversible monoamine oxidase B inhibitor. Each trial has supported, although not proven, disease-modifying effects. A third delayed-start-design clinical trial examining potential disease-modifying effects of pramipexole has unfortunately reportedly been negative according to preliminary presentations. The suggestion that rasagiline is disease modifying is made all the more compelling by in vitro and PD animal-model studies in which rasagiline was shown to have neuroprotective effects. In this review, we examine efforts to demonstrate neuroprotection in PD to date, describe ongoing neuroprotection trials, and critically discuss the results of the most recent delayed-start clinical trials that test possible disease-modifying activities of rasagiline and pramipexole in PD.
67 schema:genre research_article
68 schema:inLanguage en
69 schema:isAccessibleForFree false
70 schema:isPartOf N1ba70b78b9c34096ab1cdb89c1223aee
71 N5fff79cdffa54542a9109fb53759b7d5
72 sg:journal.1100990
73 schema:name Disease Modification in Parkinson’s Disease
74 schema:pagination 605-615
75 schema:productId N4acb02871eed4c2bbadc76edf1685c86
76 N6c946d2f2be24b1486cd589d6614e622
77 Nb24ef9b4de914e788f8d3e953104caa4
78 Nbaf2c94185a249178489bcdfde2f5866
79 Ne9eed0828df04ac8a05cb7224b1f05e6
80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047459014
81 https://doi.org/10.2165/11591320-000000000-00000
82 schema:sdDatePublished 2019-04-10T23:30
83 schema:sdLicense https://scigraph.springernature.com/explorer/license/
84 schema:sdPublisher N5ccde406af704673a29a9d726ef3b6d6
85 schema:url http://link.springer.com/10.2165%2F11591320-000000000-00000
86 sgo:license sg:explorer/license/
87 sgo:sdDataset articles
88 rdf:type schema:ScholarlyArticle
89 N1aef4ec64f834aefa5b4912c16df37bd rdf:first sg:person.0766701226.04
90 rdf:rest rdf:nil
91 N1ba70b78b9c34096ab1cdb89c1223aee schema:volumeNumber 28
92 rdf:type schema:PublicationVolume
93 N4acb02871eed4c2bbadc76edf1685c86 schema:name doi
94 schema:value 10.2165/11591320-000000000-00000
95 rdf:type schema:PropertyValue
96 N5ccde406af704673a29a9d726ef3b6d6 schema:name Springer Nature - SN SciGraph project
97 rdf:type schema:Organization
98 N5fff79cdffa54542a9109fb53759b7d5 schema:issueNumber 8
99 rdf:type schema:PublicationIssue
100 N685cb7a5c185440fb19dd8a628e06eec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Humans
102 rdf:type schema:DefinedTerm
103 N6c946d2f2be24b1486cd589d6614e622 schema:name pubmed_id
104 schema:value 21812497
105 rdf:type schema:PropertyValue
106 N7186cf74b70541359125954a3d6eefb8 rdf:first sg:person.0713775262.20
107 rdf:rest N1aef4ec64f834aefa5b4912c16df37bd
108 Nb23a6f7b17d84fd7a07d99e2255affad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Clinical Trials as Topic
110 rdf:type schema:DefinedTerm
111 Nb24ef9b4de914e788f8d3e953104caa4 schema:name dimensions_id
112 schema:value pub.1047459014
113 rdf:type schema:PropertyValue
114 Nb8b66adfa9184f28852ab16d41855793 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Parkinson Disease
116 rdf:type schema:DefinedTerm
117 Nbaf2c94185a249178489bcdfde2f5866 schema:name nlm_unique_id
118 schema:value 9102074
119 rdf:type schema:PropertyValue
120 Ne86d079d1a2745dbae8d2fbe4baaf23e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Disease Progression
122 rdf:type schema:DefinedTerm
123 Ne9eed0828df04ac8a05cb7224b1f05e6 schema:name readcube_id
124 schema:value e21457ab873d6e6c6da8df12d46590141fcc6f13e19f7674684b7a487e16a9bf
125 rdf:type schema:PropertyValue
126 Nf320f7ef101d44908565d40375d964a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Animals
128 rdf:type schema:DefinedTerm
129 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
130 schema:name Medical and Health Sciences
131 rdf:type schema:DefinedTerm
132 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
133 schema:name Neurosciences
134 rdf:type schema:DefinedTerm
135 sg:journal.1100990 schema:issn 1170-229X
136 1179-1969
137 schema:name Drugs & Aging
138 rdf:type schema:Periodical
139 sg:person.0713775262.20 schema:affiliation https://www.grid.ac/institutes/grid.5386.8
140 schema:familyName Henchcliffe
141 schema:givenName Claire
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713775262.20
143 rdf:type schema:Person
144 sg:person.0766701226.04 schema:affiliation https://www.grid.ac/institutes/grid.471368.f
145 schema:familyName Severt
146 schema:givenName W. Lawrence
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766701226.04
148 rdf:type schema:Person
149 sg:pub.10.1007/bf01245973 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001034297
150 https://doi.org/10.1007/bf01245973
151 rdf:type schema:CreativeWork
152 sg:pub.10.1007/s11064-010-0214-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026606925
153 https://doi.org/10.1007/s11064-010-0214-3
154 rdf:type schema:CreativeWork
155 sg:pub.10.1016/j.nurt.2008.02.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052291159
156 https://doi.org/10.1016/j.nurt.2008.02.003
157 rdf:type schema:CreativeWork
158 sg:pub.10.1038/nrneurol.2009.214 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031698289
159 https://doi.org/10.1038/nrneurol.2009.214
160 rdf:type schema:CreativeWork
161 https://app.dimensions.ai/details/publication/pub.1074268049 schema:CreativeWork
162 https://app.dimensions.ai/details/publication/pub.1074560399 schema:CreativeWork
163 https://app.dimensions.ai/details/publication/pub.1077122196 schema:CreativeWork
164 https://doi.org/10.1001/archneur.56.5.529 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053022109
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1001/archneur.59.10.1541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011372686
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1001/archneur.59.12.1937 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046569323
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1001/archneur.61.4.561 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008462073
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1001/archneur.66.1.nct90001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077897550
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1001/archneurol.2009.247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044051119
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1001/archneurol.2009.32 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017092484
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1001/jama.284.15.1931 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002894278
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1001/jama.287.13.1653 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049579881
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1002/ana.10191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014861123
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1002/ana.10609 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034488188
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1002/ana.20789 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021766477
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1002/mds.20914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052764064
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1002/mds.21918 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045646895
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1002/mds.22340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037630113
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1002/mds.22402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014766341
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1002/mds.22432 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031487403
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1002/mds.23143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030844858
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1002/syn.10239 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046243568
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/0014-2999(85)90168-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019162508
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/j.neuint.2010.06.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032101093
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/j.pneurobio.2010.06.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023363263
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/s0006-8993(99)01688-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018340868
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/s0024-3205(00)00643-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021318758
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1016/s0304-3940(02)00332-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045518608
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1016/s0892-0362(02)00221-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048620190
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1016/s1353-8020(09)70325-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028861053
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1016/s1353-8020(09)70832-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048555769
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/s1474-4422(05)70097-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003434219
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1016/s1474-4422(07)70246-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039369930
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1056/nejm199301213280305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045752174
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1056/nejmoa033447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035458376
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1056/nejmoa0809335 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034534938
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1056/nejmsm0904209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048073707
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1093/aje/kwm127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025537138
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1097/00001756-199803090-00026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016403129
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1111/j.1460-9568.2005.04438.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1003894227
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1111/j.1468-1331.2010.03088.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1007376153
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1111/j.1749-6632.2001.tb03656.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1002280769
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1126/science.2502843 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062541253
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1185/03007990903364954 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007341409
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1196/annals.1403.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023276697
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1212/01.wnl.0000201252.57661.e1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064347889
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1212/wnl.0b013e3181d7d8e2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064355163
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1212/wnl.0b013e3181d7d94b schema:sameAs https://app.dimensions.ai/details/publication/pub.1064355168
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1212/wnl.51.2.520 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064376556
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1212/wnl.56.11.1559 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064379306
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1371/journal.pone.0014053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011479076
259 rdf:type schema:CreativeWork
260 https://www.grid.ac/institutes/grid.471368.f schema:alternateName Mount Sinai Beth Israel
261 schema:name Beth Israel Mirken Department of Neurology, Beth Israel Medical Center, New York, NY, USA
262 rdf:type schema:Organization
263 https://www.grid.ac/institutes/grid.5386.8 schema:alternateName Cornell University
264 schema:name Department of Neurology and Neuroscience, Weill Medical College of Cornell University, 428 East 72nd Street, Suite 400, 10021, New York, NY, USA
265 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...